Jose “Pepe” Carmona has served as ADC Therapeutics' Chief Financial Officer since December 2022. He previously served as Chief Financial Officer of Rubius Therapeutics (2020-2022) and of Radius Health (2017-2020), and before that as Chief Financial Officer of Innocoll Holdings and of Alcon Europe, Middle East & Africa, a division of Novartis, after numerous financial management positions of increasing responsibility at Novartis. Mr. Carmona holds a B.S. in industrial civil engineering from Universidad Tecnica Federico Santa Maria and an M.B.A. from Columbia Business School.